Recombinant Human Active Heparanase/HPSE Protein, CF


Recombinant Human Active Heparanse/HPSE Protein, CF (Catalog # 7570-GH) selectively cleaves the linkage between a GlcA and an N-sulfo GlcNAc (NS) carrying either a 3-O-sulfo or a 6-O-sulfo group. Can also cleave the more
2 μg/lane of Recombinant Human Active Heparanase/HPSE Protein (Catalog # 7570-GH) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing more

Product Details

Reactivity HuSpecies Glossary
Applications Enzyme Activity

Order Details

Recombinant Human Active Heparanase/HPSE Protein, CF Summary

Details of Functionality
Measured by its ability to release biotinylated heparan sulfate from Recombinant Human Syndecan‑4 (Catalog # 2918-SD). 20 ng of Recombinant Human Active Heparanase/HPSE digestion will result in >50% of OD reduction compared with the Negative Control, as measured under the described conditions.
Chinese Hamster Ovary cell line, CHO-derived human Heparanase/HPSE protein
Gln36-Ile543 with N-terminal 6-His tag
The linker peptide from Ser110-Gln157 is removed by protease treatment
Accession #
N-terminal Sequence
His & K158
Protein/Peptide Type
Recombinant Enzymes
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<1.0 EU per 1 μg of the protein by the LAL method.


  • Enzyme Activity
Theoretical MW
43 kDa & 9 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
50-60 kDa & 7-9 kDa, reducing conditions
Read Publications using
7570-GH in the following applications:

Packaging, Storage & Formulations

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.
Supplied as a 0.2 μm filtered solution in Tris, NaCl and E64.
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Assay Procedure
  • Assay Buffer:  50 mM Sodium Acetate, pH 5.0
  • Recombinant Human HPSE (rhHPSE) (7570-GH)
  • HPSE Substrate (Catalog # ES020)
  • Human Syndecan-4 DuoSet Kit (Catalog # DY2918)
  • 96-well Clear Plate (Catalog # DY990)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent

And the following materials that are routinely used in ELISA:

  •  Coating Buffer (Catalog # DY006)
  • Wash Buffer (25X) (Catalog # WA126)
  • Reagent Diluent (10X) (Catalog # DY995)
  • Substrate Reagent Pack (Catalog # DY999)
  • Stop Solution (Catalog # DY994)
  1. Prepare an ELISA plate by following the DuoSet kit protocol.
  2. Dilution factor determination:
    a. Dilute the HPSE Substrate stock 100-fold in Reagent Diluent (this will be the first dilution point).
    b. Further prepare a 2-fold serial dilution series of the above diluted HPSE Substrate with Reagent Diluent for 6 points.
    c. Load 100 µL of each point onto the prepared ELISA plate in duplicate. Load 100 µL of Reagent Diluent to 2 separate  wells for blank control.
    d. Cover the plate and incubate at room temperature for 2 hours.
    e. Follow the DuoSet Assay Procedure from step 4 to step 9 to complete the assay.
    f. Determine the dilution factor (n) that achieves an OD between 1.8-3.0.
  3. rhHPSE Activity Detection:
    a. Dilute the HPSE Substrate stock by n/10-fold in Assay Buffer, diute rhHPSE to 2 μg/mL in assay buffer.
    b. Combine 10 µL of rhHPSE with 10 µL of the diluted HPSE Substrate in a vial. For negative control, combine 10 µL of Assay Buffer and 10 µL of the diluted HPSE Substrate in a vial.
    c. Incubate reactions and negative control at 37 °C for 2 hours.
    d. After incubation, heat all reactions and negative control at 95 °C for 2 minutes to inactivate rhHPSE.
    e. Add 220 µL of Reagent Diluent to each reaction and negative control. Mix well.
    f. Load 100 µL of each sample onto the prepared ELISA plate in duplicate.
    g. Cover the plate and incubate for 2 hours at room temperature.
    h. Follow the DuoSet Assay Procedure form step 4 to step 9 to complete the assay.
  4. Calculate % OD reduction compared with the negative control: 

 [1-(OD of rhHPSE sample/OD of negative control)] x 100 = % OD reduction

Per Reaction:

rhHPSE: 20 ng


This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human Active Heparanase/HPSE Protein, CF

  • EC 3.2
  • Endo-glucoronidase
  • HEP
  • Heparanase
  • Heparanase-1
  • HPA1
  • HPAheparanase exon 9 and 10 deletion
  • HPR1
  • HPSE
  • HPSE1heparanase-1
  • HSE1
  • HSE1heparanase exon10-deletion


Heparanase (HPSE) selectively cleaves heparan sulfate at specific sites on heparan sulfate proteoglycans (HSPGs) (1, 2, 3, 4). The enzyme is synthesized as an inactive 65 kDa proenzyme that is secreted via the Golgi apparatus and associates with the cell membrane through interaction with HSPGs (5). It is then endocytosed and transferred to lysosomes (6) where cathepsin L activates it by removing an internal inhibitory peptide, forming a heterodimer composed of an 8 kDa and a 50 kDa subunit (7, 8). Under certain stimuli, the active enzyme is transferred back to the cell surface, where it participates in extracellular matrix degradation and remodeling (9). HPSE facilitates cell migration associated with metastasis, wound healing and inflammation (10). An increase in its activity is associated with an increase in VEGF activity, which further enhances angiogenesis (11). HPSE also enhances shedding of syndecans and increases endothelial invasion and angiogenesis in myelomas (12). It acts as a procoagulant by increasing the generation of activation factor X in the presence of tissue factor and activation factor VII (13). In addition, it increases cell adhesion to the extracellular matrix (ECM), independent of its enzymatic activity (14). HPSE is highly expressed in placenta and spleen and weakly expressed in lymph node, thymus, peripheral blood leukocytes, bone marrow, endothelial cells, fetal liver and tumor tissues (15). The enzyme activity of recombinant human HPSE was assayed in an ELISA format using non-reducing end biotinylated heparan sulfate on recombinant syndecan 4 as a substrate (16).
  1. Vlodavsky, I. et al. (1999) Nat. Med. 5:793.
  2. Hulett, M.D. et al. (1999) Nat. Med. 5:803.
  3. Gong, F. et al. (2003) J. Biol. Chem. 278:35152.
  4. Peterson, S.B. and Liu, J. (2010) J. Biol. Chem. 285:14504.
  5. Nadav L. et al. (2002) J. Cell Sci. 115:2179.
  6. Gingis-Velitski, S. et al. (2004) J. Biol. Chem. 279:44084.
  7. Abboud-Jarrous, G. et al. (2008) J. Biol. Chem. 283:18167.
  8. Zetser, A. et al. (2004) J. Cell Sci. 117:2249.
  9. Zcharia E. et al. (2001) J. Mammary Gland Biol. Neoplasia 6:311.
  10. Fux, L. et al. (2009) Trends Biochem. Sci. 34:511.
  11. Cohen-Kaplan, V. et al. (2008) Int. J. Cancer 123:2566.
  12. Purushothaman, A. et al. (2010) Blood 115:2449.
  13. Nadir, Y. et al. (2010) Haematologica 95:1927.
  14. Goldshmidt, O. et al. (2003) FASEB J. 17:1015.
  15. Kussie, P.H. et al. (1999) Biochem. Biophys. Res. Commun. 261:183.
  16. Wu, Z.L. et al. (2017) Glycobiology 27:518.

Customers Who Viewed This Item Also Viewed...

Species: Hu, Mu, Po, Rt, Sh
Applications: Flow, ICC/IF, IHC, IHC-P, PEP-ELISA, WB
Species: Hu
Applications: ELISA, IHC, IHC-P, S-ELISA, WB
Species: Gp, Hu, Mu, Rb, Rt, Sh, Ye
Applications: B/N, ChIP, Flow, GS, ICC/IF, IHC, IHC-P, IP, WB
Species: Hu
Applications: IHC, WB
Species: Hu
Applications: ELISA
Species: Hu
Applications: BA
Species: Hu, Mu, Rt
Applications: IHC, IHC-P, WB
Species: Hu, Mu, Rt
Applications: Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IM, IP, KD, WB
Species: Hu
Applications: CyTOF-ready, Flow, WB
Species: Bv, Hu, Mu
Applications: CyTOF-ready, ICC, IHC, ICFlow
Species: Hu, Rt
Applications: ELISA, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, KO, WB
Species: Hu
Applications: ELISA(Cap), ELISA(Det), ELISA(Sta), IHC, Neut, WB
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Ch, Hu, Mu, Rb, Rt, Sh
Applications: B/N, Flow, ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: ELISA
Species: Hu
Applications: Enzyme Activity

Publications for Heparanase/HPSE (7570-GH)(13)

We have publications tested in 3 confirmed species: Human, Mouse, N/A.

We have publications tested in 3 applications: Bioassay, Click Chemistry, Western Blot.

Filter By Application
Click Chemistry
Western Blot
All Applications
Filter By Species
All Species
Showing Publications 1 - 10 of 13. Show All 13 Publications.
Publications using 7570-GH Applications Species
Manseur, C;Groult, H;Porta, M;Bodet, PE;Mersni-Achour, R;Petit, R;Ali-Moussa, S;Musnier, B;Le Cerf, D;Varacavoudin, T;Haddad, O;Sutton, A;Leal, CEY;Alencar-Filho, EB;Piot, JM;Bridiau, N;Maugard, T;Fruitier-Arnaudin, I; A Screening Approach to Assess the Impact of Various Commercial Sources of Crude Marine ?-Carrageenan on the Production of Oligosaccharides with Anti-heparanase and Anti-migratory Activities Marine drugs 2023-05-11 [PMID: 37233489] (Bioassay, N/A) Bioassay N/A
P He, X Zhang, K Xia, DE Green, S Baytas, Y Xu, T Pham, J Liu, F Zhang, A Almond, RJ Linhardt, PL DeAngelis Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors Nature Communications, 2022-12-02;13(1):7438. 2022-12-02 [PMID: 36460670] (Bioassay) Bioassay
R Cousin, H Groult, C Manseur, R Ferru-Clém, M Gani, R Havret, C Toucheteau, G Prunier, B Colin, F Morel, JM Piot, I Lanneluc, K Baranger, T Maugard, I Fruitier-A A Marine lambda-Oligocarrageenan Inhibits Migratory and Invasive Ability of MDA-MB-231 Human Breast Cancer Cells through Actions on Heparanase Metabolism and MMP-14/MMP-2 Axis Marine Drugs, 2021-09-28;19(10):. 2021-09-28 [PMID: 34677445] (Bioassay, Human) Bioassay Human
KA Queisser, RA Mellema, EA Middleton, I Portier, BK Manne, F Denorme, EJ Beswick, MT Rondina, RA Campbell, AC Petrey COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction JCI Insight, 2021-09-08;0(0):. 2021-09-08 [PMID: 34314391] (Bioassay, Human) Bioassay Human
J Garcia, HS McCarthy, JH Kuiper, J Melrose, S Roberts Perlecan in the Natural and Cell Therapy Repair of Human Adult Articular Cartilage: Can Modifications in This Proteoglycan Be a Novel Therapeutic Approach? Biomolecules, 2021-01-13;11(1):. 2021-01-13 [PMID: 33450893] (Bioassay, Human) Bioassay Human
K Ko, T Suzuki, R Ishikawa, N Hattori, R Ito, K Umehara, T Furihata, N Dohmae, RJ Linhardt, K Igarashi, T Toida, K Higashi Ischemic stroke disrupts the endothelial glycocalyx through activation of proHPSE via acrolein exposure J Biol Chem, 2020-10-30;0(0):. 2020-10-30 [PMID: 33127645] (Bioassay, Human) Bioassay Human
F Njau, N Shushakova, H Schenk, VC Wulfmeyer, R Bollin, J Menne, H Haller Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice PLoS ONE, 2020-01-14;15(1):e0218494. 2020-01-14 [PMID: 31935212] (Human) Human
Y Kiyan, S Tkachuk, K Kurselis, N Shushakova, K Stahl, D Dawodu, R Kiyan, B Chichkov, H Haller Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling Sci Rep, 2019-09-19;9(1):13591. 2019-09-19 [PMID: 31537875] (Bioassay, Human) Bioassay Human
Wu Z, Person A, Anderson M, Burroughs B, Tatge T, Khatri K, Zou Y, Wang L, Geders T, Zaia J, Sackstein R Imaging specific cellular glycan structures using glycosyltransferases via click chemistry. Glycobiology, 2018-02-01;0(0):. 2018-02-01 [PMID: 29186441] (Click Chemistry, Human, Mouse) Click Chemistry Human, Mouse
N Poupard, P Badarou, F Fasani, H Groult, N Bridiau, F Sannier, S Bordenave-, C Kieda, JM Piot, C Grillon, I Fruitier-A, T Maugard Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of ?-Carrageenan Derivative as a Potent Anti Angiogenic Agent Mar Drugs, 2017-05-09;15(5):. 2017-05-09 [PMID: 28486399] (Bioassay) Bioassay
Show All 13 Publications.

Reviews for Heparanase/HPSE (7570-GH) (0)

There are no reviews for Heparanase/HPSE (7570-GH). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for Heparanase/HPSE (7570-GH) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Heparanase/HPSE Products

Bioinformatics Tool for Heparanase/HPSE (7570-GH)

Discover related pathways, diseases and genes to Heparanase/HPSE (7570-GH). Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
Visit Tool

Diseases for Heparanase/HPSE (7570-GH)

Discover more about diseases related to Heparanase/HPSE (7570-GH).

Pathways for Heparanase/HPSE (7570-GH)

View related products by pathway.

PTMs for Heparanase/HPSE (7570-GH)

Learn more about PTMs related to Heparanase/HPSE (7570-GH).

Blogs on Heparanase/HPSE

There are no specific blogs for Heparanase/HPSE, but you can read our latest blog posts.

Customers Who Bought This Also Bought

Contact Information

Product PDFs


Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.


Review this Product

Be the first to review our Recombinant Human Active Heparanase/HPSE Protein, CF and receive a gift card or discount.


Gene Symbol HPSE